Global Noninvasive Prenatal Testing (NIPT) Market US$ 2.8 Billion by 2021

Global Noninvasive Prenatal Testing (NIPT) Market US$ 2.8 Billion by 2021

According to a new market research report published by iHealthcareAnalyst, Inc., Noninvasive Prenatal Testing Market – Global NIPT Marketed Tests Analysis and Forecast 2017-2021, the global noninvasive prenatal testing market is estimated to reach US$ 2.3 Billion in 2020, expanding at a CAGR of 20.66% from 2017 to 2021.

Visit the Noninvasive Prenatal Testing Market – Global NIPT Marketed Tests Analysis and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/non-invasive-prenatal-testing-market/

Prenatal diagnosis or prenatal screening refers to testing for diseases or conditions in a fetus or embryo before it is born. NIPT test can detect birth defects such as neural tube defects, Down syndrome, chromosome abnormalities, genetic disorders and other conditions, such as spina bifida, cleft palate, Tay–Sachs disease, sickle cell anemia, thalassemia, cystic fibrosis, Muscular dystrophy, and fragile X syndrome. The global noninvasive prenatal testing market report estimates the market size (Revenue US$ million – 2014 to 2021) for market segmentation based on NIPT-specific test types (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verify, VisibiliT, etc.), and forecasts growth trends (CAGR% – 2017 to 2021). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent acquisitions and alliances.

The global noninvasive prenatal testing market is segmented as:

  1. Diagnostic Test Type
    • BambniTest
    • Harmony Test
    • informaSeq Test
    • MaterniT21 PLUS
    • NIFTY Test
    • Panorama Test
    • PrenaTest
    • Verify Test
    • VisibiliT Test
    • Others
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Ariosa Diagnostics, Inc.
    • Berry Genomics Co., Ltd.
    • BGI Diagnostics
    • Illumina, Inc.
    • Laboratory Corporation of America Holdings (LabCorp)
    • LifeCodexx AG
    • Natera, Inc.
    • Sequenom, Inc.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2017-11-05T19:09:05+00:00 Categories: Press Releases|